Medostic
Medostic is an early stage digital therapeutics company focused on developing closed-loop systems for critical care. Their mission is to improve metabolic monitoring and personalized nutritive therapy for critically ill patients through innovative software, diagnostics, therapeutics, and devices, with a focus on glycemic control, inflammation, and nutrition.
Industries
Nr. of Employees
small (1-50)
Products
Closed-loop metabolic support system (in development)
Integrated system concept combining diagnostic monitoring, control algorithms, infusion devices and therapeutic formulations to manage patient metabolic state in critical care.
Metabolic and nutritive therapeutic formulations (in clinical trials)
Therapeutic and nutritive formulations intended to support metabolic needs (including lactate supplementation approaches) in critically ill patients; currently in clinical evaluation.
Inpatient metabolomic monitoring and decision support (research/clinical use)
Monitoring approach combining glucose, lactate and other metabolite measurements with decision-support algorithms to inform bedside therapeutic decisions.
Closed-loop metabolic support system (in development)
Integrated system concept combining diagnostic monitoring, control algorithms, infusion devices and therapeutic formulations to manage patient metabolic state in critical care.
Metabolic and nutritive therapeutic formulations (in clinical trials)
Therapeutic and nutritive formulations intended to support metabolic needs (including lactate supplementation approaches) in critically ill patients; currently in clinical evaluation.
Inpatient metabolomic monitoring and decision support (research/clinical use)
Monitoring approach combining glucose, lactate and other metabolite measurements with decision-support algorithms to inform bedside therapeutic decisions.
Services
Design and development of software to personalize metabolic therapy for critical care patients, intended for regulatory clearance as a medical device.
Development and integration of metabolite biosensing with algorithms to support closed-loop infusion and therapeutic control.
Development of nutritive and metabolic therapeutic formulations with progression into clinical trials for critical care indications.
Support for regulatory submission planning (including pre-IND) and alignment of patent strategy with clinical and regulatory plans.
Design and development of software to personalize metabolic therapy for critical care patients, intended for regulatory clearance as a medical device.
Development and integration of metabolite biosensing with algorithms to support closed-loop infusion and therapeutic control.
Development of nutritive and metabolic therapeutic formulations with progression into clinical trials for critical care indications.
Support for regulatory submission planning (including pre-IND) and alignment of patent strategy with clinical and regulatory plans.
Expertise Areas
- Clinical decision support for inpatient metabolic care
- Biosensor-based metabolomics
- Closed-loop control systems for critical care
- Formulation and therapeutic development for metabolic/nutritive therapy
Key Technologies
- Biosensor metabolite measurement (glucose, lactate)
- Metabolomics monitoring
- Closed-loop control algorithms
- Inpatient clinical decision support software (SaMD)